ArgiNOx Phamaceuticals

About:

Arginox Pharmaceuticals is a biopharmaceutical company engaged in the discovery and development of drugs for cardiovascular pathologies.

Website: http://www.arginox.com

Top Investors: Topspin Partners, Perseus-Soros Biopharmaceutical Fund

Description:

Arginox Pharmaceuticals is a biopharmaceutical company engaged in the discovery and development of drugs for cardiovascular pathologies. It offers Tilarginine Acetate Injection that inhibits the production of nitric oxide, which is used for the treatment of cardiogenic shocks. Arginox Pharmaceuticals is based in Redwood City, California.

Total Funding Amount:

$41.3M

Headquarters Location:

Redwood City, California, United States

Founded Date:

2000-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2005-03-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai